Reimbursement

HHS should ensure 340B hospitals remain eligible despite changes in payer mix, AHA says

Hospitals participating in the 340B Drug Pricing Program could lose access due to payer mix changes stemming from the COVID-19 pandemic unless HHS issues a waiver.

Nick Hut April 1, 2021

Financial Analytics Leadership Council members share 5 challenges, responses to pandemic’s financial long haul

Financial leaders discuss how the pandemic has impacted revenue, volume and expenses, which has thus created a need for data and analytics.

HFMA March 31, 2021

Risk contracting: Outlook and success factors for hospitals and health systems

An December 2020 HFMA survey, sponsored by GHX, found high levels of optimism, overall regarding the future of value-based payment.

Eric C. Reese, PhD March 30, 2021

Implications of the HFMA-GHX study of risk-based contracting

In this article discussing implications of the findings of a December 2020 HFMA study, sponsored by GHX, healthcare leaders share their perspectives on key factors contributing to their organizations' success under value-based contracts.

Eric C. Reese, PhD March 30, 2021

News briefs: The new COVID-19 relief legislation could result in a big Medicare payment cut

The $1.9 trillion American Rescue Plan, which was signed into law March 11, could lead to a significant reduction in Medicare revenues if Congress does not act.

Nick Hut March 30, 2021

Survey responses provide snapshot of the toll of the COVID-19 pandemic on hospital finances

A government-issued report used survey responses from hospital administrators to examine the impact of the COVID-19 pandemic on hospitals in various aspects, including finances.

Nick Hut March 30, 2021

3 questions with Katie Gilfillan: Why it’s time for the healthcare industry to address cost effectiveness of health

HFMA’s director of professional practice and clinical relationships discusses the importance of the Association’s Cost Effectiveness of Health event.

Deborah Filipek March 29, 2021

Congressional hearing showcases the divergence in the two parties’ views on how to improve U.S. healthcare

One witness at a hearing of a House subcommittee touted price transparency as an essential tool for addressing healthcare costs.

Nick Hut March 27, 2021

Health system leaders state their case for prolonging the moratorium on the Medicare payment sequester

Hospitals and health systems urgently need Congress to extend the freeze on the 2% Medicare payment sequester, industry leaders said.

Nick Hut March 25, 2021

Health system leaders share top approaches for success under value-based payment

Three health system executives discuss the key factors that have contributed to their organizations’ long-standing success with value-based payment models.

Eric C. Reese, PhD March 25, 2021
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );